InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,466.43
(
-1.01%
)
US TECH 100
18,646.00
(
-1.04%
)
Dow Jones
40,346.53
(
-1.22%
)
Brent Oil
80.29
(
-1.50%
)
Bitcoin
62,818.18
(
-2.76%
)
Post# of 427543
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

HerbieRay

Send PM Follow Ignore
Followers 3
Posts 1053
Boards Moderated 0
Alias Born 12/14/2014

HerbieRay

Re: Sam81 post# 190338

Monday, 05/06/2019 8:57:44 AM

Monday, May 06, 2019 8:57:44 AM

Post# of 427543
MATINAS BIOPHARMA has been pumping their trial drug based on Reduce-it outcome. Just wondering if Amarin can stop this in the same way they are stopping Coromega and (presumably) Omax.

Maybe not worth the effort?

Any thoughts.

TIA, HR
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM

Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM

VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM

Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM

Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM

Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!